HEADER ISOMERASE 11-JUN-21 7F2J TITLE CRYSTAL STRUCTURE OF ATFKBP53 FKBD IN COMPLEX WITH RAPAMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP53; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN; COMPND 5 SYNONYM: PPIASE FKBP53,FK506-BINDING PROTEIN 53,ATFKBP53,IMMUNOPHILIN COMPND 6 FKBP53,ROTAMASE; COMPND 7 EC: 5.2.1.8; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ARABIDOPSIS THALIANA; SOURCE 3 ORGANISM_COMMON: MOUSE-EAR CRESS; SOURCE 4 ORGANISM_TAXID: 3702; SOURCE 5 GENE: FKBP53, AT4G25340, T30C3_20; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS FKBP, RAPAMYCIN, DIMERIZATION, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.K.SINGH,K.SAHARAN,D.VASUDEVAN REVDAT 3 29-NOV-23 7F2J 1 REMARK REVDAT 2 23-MAR-22 7F2J 1 JRNL REVDAT 1 09-MAR-22 7F2J 0 JRNL AUTH A.K.SINGH,K.SAHARAN,S.BARAL,S.LUAN,D.VASUDEVAN JRNL TITL CRYSTAL PACKING REVEALS RAPAMYCIN-MEDIATED HOMODIMERIZATION JRNL TITL 2 OF AN FK506-BINDING DOMAIN. JRNL REF INT.J.BIOL.MACROMOL. V. 206 670 2022 JRNL REFN ISSN 0141-8130 JRNL PMID 35218805 JRNL DOI 10.1016/J.IJBIOMAC.2022.02.107 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 31104 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1666 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2273 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE SET COUNT : 127 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1778 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 162 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04000 REMARK 3 B22 (A**2) : 0.48000 REMARK 3 B33 (A**2) : -0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.086 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.087 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.010 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2010 ; 0.009 ; 0.017 REMARK 3 BOND LENGTHS OTHERS (A): 2023 ; 0.001 ; 0.019 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2723 ; 1.417 ; 1.893 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4687 ; 1.008 ; 2.601 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 246 ; 6.697 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 98 ;26.135 ;19.592 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 344 ;11.396 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;15.549 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 296 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2194 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 432 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 945 ; 3.390 ; 1.347 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 944 ; 3.390 ; 1.346 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1183 ; 3.816 ; 2.007 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1184 ; 3.819 ; 2.008 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1065 ;12.267 ; 1.968 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1066 ;12.262 ; 1.970 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1534 ;14.844 ; 2.733 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2059 ;15.416 ;17.327 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2053 ;15.432 ;17.251 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 1.00 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7F2J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1300022712. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9677 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32798 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 47.010 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.54100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 6J2M REMARK 200 REMARK 200 REMARK: ROD-SHAPED REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LITHIUM SULFATE MONOHYDRATE, 0.1 REMARK 280 M BIS-TRIS (PH 6.5), 25% W/V PEG 3350, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.97450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 479 REMARK 465 HIS A 480 REMARK 465 HIS A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 SER B 362 REMARK 465 GLU B 479 REMARK 465 HIS B 480 REMARK 465 HIS B 481 REMARK 465 HIS B 482 REMARK 465 HIS B 483 REMARK 465 HIS B 484 REMARK 465 HIS B 485 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 477 -72.02 -91.97 REMARK 500 ALA B 457 107.91 -161.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6J2M RELATED DB: PDB REMARK 900 WITH A DIFFERENT LIGAND DBREF 7F2J A 362 477 UNP Q93ZG9 FKB53_ARATH 362 477 DBREF 7F2J B 362 477 UNP Q93ZG9 FKB53_ARATH 362 477 SEQADV 7F2J LEU A 478 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J GLU A 479 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS A 480 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS A 481 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS A 482 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS A 483 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS A 484 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS A 485 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J LEU B 478 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J GLU B 479 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS B 480 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS B 481 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS B 482 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS B 483 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS B 484 UNP Q93ZG9 EXPRESSION TAG SEQADV 7F2J HIS B 485 UNP Q93ZG9 EXPRESSION TAG SEQRES 1 A 124 SER GLN VAL ARG THR TYR PRO ASN GLY LEU ILE VAL GLU SEQRES 2 A 124 GLU LEU SER MET GLY LYS PRO ASN GLY LYS ARG ALA ASP SEQRES 3 A 124 PRO GLY LYS THR VAL SER VAL ARG TYR ILE GLY LYS LEU SEQRES 4 A 124 GLN LYS ASN GLY LYS ILE PHE ASP SER ASN ILE GLY LYS SEQRES 5 A 124 SER PRO PHE LYS PHE ARG LEU GLY ILE GLY SER VAL ILE SEQRES 6 A 124 LYS GLY TRP ASP VAL GLY VAL ASN GLY MET ARG VAL GLY SEQRES 7 A 124 ASP LYS ARG LYS LEU THR ILE PRO PRO SER MET GLY TYR SEQRES 8 A 124 GLY VAL LYS GLY ALA GLY GLY GLN ILE PRO PRO ASN SER SEQRES 9 A 124 TRP LEU THR PHE ASP VAL GLU LEU ILE ASN VAL GLN LEU SEQRES 10 A 124 GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 124 SER GLN VAL ARG THR TYR PRO ASN GLY LEU ILE VAL GLU SEQRES 2 B 124 GLU LEU SER MET GLY LYS PRO ASN GLY LYS ARG ALA ASP SEQRES 3 B 124 PRO GLY LYS THR VAL SER VAL ARG TYR ILE GLY LYS LEU SEQRES 4 B 124 GLN LYS ASN GLY LYS ILE PHE ASP SER ASN ILE GLY LYS SEQRES 5 B 124 SER PRO PHE LYS PHE ARG LEU GLY ILE GLY SER VAL ILE SEQRES 6 B 124 LYS GLY TRP ASP VAL GLY VAL ASN GLY MET ARG VAL GLY SEQRES 7 B 124 ASP LYS ARG LYS LEU THR ILE PRO PRO SER MET GLY TYR SEQRES 8 B 124 GLY VAL LYS GLY ALA GLY GLY GLN ILE PRO PRO ASN SER SEQRES 9 B 124 TRP LEU THR PHE ASP VAL GLU LEU ILE ASN VAL GLN LEU SEQRES 10 B 124 GLU HIS HIS HIS HIS HIS HIS HET RAP A 501 65 HET SO4 A 502 5 HET SO4 A 503 5 HET SO4 A 504 5 HET SO4 A 505 5 HET RAP B 501 65 HET SO4 B 502 5 HET PEG B 503 7 HETNAM RAP RAPAMYCIN IMMUNOSUPPRESSANT DRUG HETNAM SO4 SULFATE ION HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 3 RAP 2(C51 H79 N O13) FORMUL 4 SO4 5(O4 S 2-) FORMUL 10 PEG C4 H10 O3 FORMUL 11 HOH *85(H2 O) HELIX 1 AA1 ILE A 426 ASN A 434 1 9 HELIX 2 AA2 PRO A 447 GLY A 451 5 5 HELIX 3 AA3 ILE B 426 ASN B 434 1 9 HELIX 4 AA4 PRO B 447 GLY B 451 5 5 SHEET 1 AA1 6 VAL A 364 THR A 366 0 SHEET 2 AA1 6 ILE A 372 SER A 377 -1 O VAL A 373 N ARG A 365 SHEET 3 AA1 6 LYS A 441 ILE A 446 -1 O LYS A 443 N GLU A 374 SHEET 4 AA1 6 LEU A 467 VAL A 476 -1 O LEU A 467 N ILE A 446 SHEET 5 AA1 6 THR A 391 LEU A 400 -1 N LYS A 399 O THR A 468 SHEET 6 AA1 6 ILE A 406 SER A 409 -1 O ASP A 408 N GLY A 398 SHEET 1 AA2 6 VAL A 364 THR A 366 0 SHEET 2 AA2 6 ILE A 372 SER A 377 -1 O VAL A 373 N ARG A 365 SHEET 3 AA2 6 LYS A 441 ILE A 446 -1 O LYS A 443 N GLU A 374 SHEET 4 AA2 6 LEU A 467 VAL A 476 -1 O LEU A 467 N ILE A 446 SHEET 5 AA2 6 THR A 391 LEU A 400 -1 N LYS A 399 O THR A 468 SHEET 6 AA2 6 PHE A 416 ARG A 419 -1 O PHE A 416 N VAL A 394 SHEET 1 AA3 6 VAL B 364 THR B 366 0 SHEET 2 AA3 6 ILE B 372 SER B 377 -1 O VAL B 373 N ARG B 365 SHEET 3 AA3 6 LYS B 441 ILE B 446 -1 O THR B 445 N ILE B 372 SHEET 4 AA3 6 LEU B 467 GLN B 477 -1 O LEU B 467 N ILE B 446 SHEET 5 AA3 6 THR B 391 LEU B 400 -1 N LYS B 399 O THR B 468 SHEET 6 AA3 6 ILE B 406 SER B 409 -1 O ASP B 408 N GLY B 398 SHEET 1 AA4 6 VAL B 364 THR B 366 0 SHEET 2 AA4 6 ILE B 372 SER B 377 -1 O VAL B 373 N ARG B 365 SHEET 3 AA4 6 LYS B 441 ILE B 446 -1 O THR B 445 N ILE B 372 SHEET 4 AA4 6 LEU B 467 GLN B 477 -1 O LEU B 467 N ILE B 446 SHEET 5 AA4 6 THR B 391 LEU B 400 -1 N LYS B 399 O THR B 468 SHEET 6 AA4 6 PHE B 416 ARG B 419 -1 O PHE B 418 N VAL B 392 CRYST1 28.301 73.949 61.950 90.00 101.01 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.035334 0.000000 0.006876 0.00000 SCALE2 0.000000 0.013523 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016445 0.00000